Clinical Correlates of Cerebral Amyloid Deposition in Parkinson’s Disease Dementia: Evidence from a PET Study
- 23 July 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 70 (2) , 597-609
Abstract
Background: Dementia in Parkinson’s disease (PDD) is common presumably due to combined neuropathological substrates. Amyloid-β (Aβ) plaques are well described in PDD but their contribution in synucleinopathies is still controversial. Objective: To inKeywords
This publication has 54 references indexed in Scilit:
- Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologiesNature Reviews Neuroscience, 2013
- Pathologic Accumulation of α-Synuclein and Aβ in Parkinson Disease Patients With DementiaArchives of Neurology, 2012
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- Amyloid imaging of Lewy body‐associated disordersMovement Disorders, 2010
- Parkinson Disease With DementiaAlzheimer Disease & Associated Disorders, 2009
- Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomographyMovement Disorders, 2009
- Imaging amyloid deposition in Lewy body diseasesNeurology, 2008
- [11C]PIB binding in Parkinson's disease dementiaNeuroImage, 2008
- Lewy body cortical involvement may not always predict dementia in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984